SummaryThe interleukin 2 receptor (IL-2K) is known to be comprised of at least three genetically distinct subunits termed c~, B, and 3/. These chains can be expressed individually or in various combinations resulting in distinct receptors with different affinities for IL-2. In contrast to a and/8, the cell surface expression of the 3' chain protein previously has not been well-characterized. To examine cell surface expresssion of IL-2R3, on hematopoietic cells, we developed two new monoclonal antibodies (mAbs) specific for this protein. Both 1All (immunoglobulin [IgG1]) and 3Gll (IgM) specifically reacted with murine cells transfected with IL-2K3" cDNA, and immunoprecipitation studies indicated that both antibodies precipitated a protein of approximately 62-65 kD. Scatchard analysis of IL-2 binding to murine cells transfected with cDNA-encoding combinations of IL-2R components demonstrated that neither B nor 3, chain bind IL-2 with measurable affinity, but coexpression of both/8 and 3' is sufficient to form an intermediate affinity receptor. In the absence of 3' chain,/8 chain interacts with ot chain to form a "pseudo-high" affinity receptor. In contrast, 3' chain does not appear capable of interacting with a chain in the absence of/8 chain. Thus, 3' chain appears to interact only with/~, but ~ chain is capable of interacting with both ot and 3'. Using the newly developed mAbs to examine cell surface expression by immunofluorescence, resting T cells were found to express low levels of 3' chain without detectable a or/8. Early after mitogen stimulation, T cells expressed higher levels of oe,/~, and 3'. However, at later time points, T cells expressed ot and 3' in marked excess over/8. Thus, formation of high affinity IL-2R on activated T cells was primarily limited by/8 chain expression. In contrast, resting natural killer (NK) cells constitutively expressed IL-2RB without detectable cr or 3'. After activation with either IL-2 or IL-12, expression of both c~ and 3' transiently increased and then returned to very low levels. Expression of functional IL-2R on resting and activated NK cells, therefore, appeared to be primarily limited by the expression of 3' chain. IL-2 binding studies with resting NK cells confirmed the results ofimmunofluorescence studies indicating the presence of very low numbers of intermediate affinity (/~3') receptors for IL-2 on these cells. NK cells obtained from patients receiving IL-2 therapy were phenotypically similar to resting NK cells. These studies have identified marked differences in IL-2R composition in two different types of cytotoxic lymphocytes, further underscoring the complexity of this receptor/ligand system. With new reagents specific for IL-2R3", it will now be possible to examine further the functional significance of these differences.